| Previous Close | 2.22 |
| Open | 2.22 |
| Bid | 2.11 x 900 |
| Ask | 2.14 x 3000 |
| Day's Range | 2.10 - 2.22 |
| 52 Week Range | 1.65 - 4.69 |
| Volume | 79,106 |
| Avg. Volume | 199,918 |
| Market Cap | 42.34M |
| Beta | 1.37 |
| PE Ratio (TTM) | -1.60 |
| EPS (TTM) | -1.32 |
| Earnings Date | Nov 13, 2017 - Nov 17, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.00 |
- Associated Press•12 days ago
Imprimis posts 2Q profit
On a per-share basis, the San Diego-based company said it had net income of 6 cents. The pharmaceutical and drug compounding company posted revenue of $6.9 million in the period. In the final minutes of ...
- PR Newswire•12 days ago
Imprimis Pharmaceuticals Announces Second Quarter 2017 Financial Results
SAN DIEGO , Aug. 10, 2017 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, today reported financial results for the second quarter 2017. ...
- ACCESSWIRE•12 days ago
Investor Network: Imprimis Pharmaceuticals, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / August 10, 2017 / Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY ) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, August 10, 2017 ...
